Drugs / Tc-94m sestamibi
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00082368 | May 2004 → Apr 2014 | cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tc-94m sestamibi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00082368 ↗ |
| Modality | Diagnostic / imaging agent | “a PET imaging agent” NCT00082368 ↗ |
| Route | Intravenous | “Tc-94m sestamibi is injected into a vein” NCT00082368 ↗ |